Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07740655) titled 'Low-dose Versus Standard-dose Remimazolam for Prevention of Emergence Agitation After Nasal Surgery' on July 23.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Jeju National University School of Medicine
Condition:
Emergence Agitation
General Anesthesia
Nasal Surgical Procedures
Intervention:
Drug: Remimazolam
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: July 24, 2026
Target Sample Size: 138...